statistiche ricercatore

PEGHIN, MADDALENA

Distribuzione geografica

Continente	#
EU - Europa	3.257
NA - Nord America	2.251
AS - Asia	1.504
SA - Sud America	266
AF - Africa	23
Continente sconosciuto - Info sul continente non disponibili	5
OC - Oceania	2
Totale	7.308

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	2.284
US - Stati Uniti d'America	2.187
SG - Singapore	719
HK - Hong Kong	319
IE - Irlanda	242
CN - Cina	237
BR - Brasile	230
GB - Regno Unito	184
SE - Svezia	147
RU - Federazione Russa	112
FI - Finlandia	79
IN - India	61
DE - Germania	59
VN - Vietnam	59
CA - Canada	36
JP - Giappone	33
NL - Olanda	26
MX - Messico	25
ES - Italia	24
AT - Austria	21
BD - Bangladesh	21
PL - Polonia	17
FR - Francia	16
CZ - Repubblica Ceca	15
UA - Ucraina	15
AR - Argentina	14
TR - Turchia	13
IQ - Iraq	9
CO - Colombia	7
EC - Ecuador	7
EG - Egitto	6
ZA - Sudafrica	6
LT - Lituania	5
AE - Emirati Arabi Uniti	4
CH - Svizzera	4
EU - Europa	4
JO - Giordania	4
PK - Pakistan	4
DZ - Algeria	3
ID - Indonesia	3
PY - Paraguay	3
SY - Repubblica araba siriana	3
UZ - Uzbekistan	3
VE - Venezuela	3
AU - Australia	2
CL - Cile	2
KG - Kirghizistan	2
MA - Marocco	2
NP - Nepal	2
SA - Arabia Saudita	2
UG - Uganda	2
AL - Albania	1
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BB - Barbados	1
BE - Belgio	1
BG - Bulgaria	1
BH - Bahrain	1
DK - Danimarca	1
GA - Gabon	1
HN - Honduras	1
HU - Ungheria	1
KE - Kenya	1
KR - Corea	1
LU - Lussemburgo	1
OM - Oman	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
TN - Tunisia	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	7.308

Salva come PNG Salva come JPEG

Città	#
Milan	1.680
Dallas	384
Singapore	338
Ashburn	332
Hong Kong	316
Dublin	242
Rome	137
Beijing	123
Boardman	116
Nyköping	114
Chandler	101
Princeton	96
London	94
Chicago	90
The Dalles	73
Helsinki	65
Los Angeles	64
Washington	60
New York	42
Fairfield	38
Tokyo	32
São Paulo	28
Pune	27
Santa Clara	27
Seattle	26
Ho Chi Minh City	24
Ogden	24
Houston	17
Nuremberg	17
Warsaw	16
Montreal	15
Brno	14
Brooklyn	14
Hanoi	14
San Diego	14
Buffalo	13
Kilburn	13
Mexico City	13
Assago	12
Dong Ket	12
Munich	12
Orem	12
Chennai	11
Poplar	11
Amsterdam	10
Jacksonville	10
Atlanta	9
Boston	9
Council Bluffs	9
Denver	9
Falkenstein	9
Lappeenranta	9
Salt Lake City	9
San Francisco	9
Vienna	9
Belo Horizonte	8
Cambridge	8
Düsseldorf	8
Stockholm	8
Woodbridge	8
Brasília	7
Portsmouth	7
Rio de Janeiro	7
Varese	7
Wilmington	7
Aldeatejada	6
Ankara	6
Goiânia	6
Hounslow	6
New Bedfont	6
Phoenix	6
Acton	5
Bogotá	5
Bologna	5
Cairo	5
Chiswick	5
Elk Grove Village	5
Johannesburg	5
Manchester	5
Shanghai	5
Toronto	5
Turku	5
Amman	4
Ann Arbor	4
Carney	4
Cavaria con Premezzo	4
Frankfurt am Main	4
Genoa	4
Mumbai	4
New Delhi	4
Pisa	4
Recife	4
Redmond	4
Tampa	4
Berlin	3
Calgary	3
Campinas	3
Caserta	3
Curitiba	3
Damascus	3
Totale	5.256

Salva come PNG Salva come JPEG

Nome	#
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections	170
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis	113
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	111
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	110
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study	106
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study	105
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant	105
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience	97
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains	95
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review	94
A look at clinical trial design for new antimicrobials for the adult population	94
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients	91
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	87
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)	85
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	84
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study	80
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	80
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients	79
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study	77
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey	77
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation	77
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	75
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study	75
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa	74
'Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': authors' response	74
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization	71
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance	71
How to manage KPC infections	70
Perioperative Antibiotic Stewardship in the Organ Transplant Setting	70
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients	68
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study	68
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series	66
Risk scores and surgery for infective endocarditis: in search of a good predictive score	66
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery	65
Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe	65
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study	65
The current treatment landscape: candidiasis	65
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa	65
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients	63
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus	63
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis	62
Community-acquired pneumonia: is less more?	62
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	61
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature	61
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	61
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature	61
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections	61
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection	61
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance	60
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia	60
COVID-19 positive donor for solid organ transplantation	60
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	60
Environmental variables associated with an increased risk of invasive aspergillosis	60
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project	60
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study	59
Prevention and Treatment of Respiratory Virus Infection	59
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam	59
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country	59
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?	59
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe	59
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis	59
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia	58
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria	58
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014	58
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia	58
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy	58
Cystic dystrophy of the pancreas in patient with only one previous cyst	58
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient	57
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)	57
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	57
Treatment of Infections Due to MDR Gram-Negative Bacteria	57
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options	57
The management of multidrug-resistant Enterobacteriaceae	57
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections	57
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study	57
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	56
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors	56
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study	55
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study	55
The safety of treatment options for acute bacterial skin and skin structure infections	55
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam	55
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies	55
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study	55
Daptomycin-containing regimens for treatment of Gram-positive endocarditis	54
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality	54
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis	53
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction	53
Important new therapies for methicillin-resistant Staphylococcus aureus	53
Recent concepts in fungal involvement in skin and soft tissue infections	52
The role of dalbavancin in skin and soft tissue infections	52
New antibiotics for ventilator-associated pneumonia	52
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?	52
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19	51
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience	50
Italian epidemiology of Gram negative bloodstream infections over 4-year period	50
Estimated burden of fungal infections in Italy	50
Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment	49
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia	48
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery	48
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6	48
Totale	6.694

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	56.035
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	56.035

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	48	0	0	0	0	0	6	5	5	6	4	4	18
2021/2022	219	0	1	0	1	2	2	0	0	112	22	2	77
2022/2023	628	48	3	7	75	44	209	2	85	94	29	16	16
2023/2024	2.797	386	446	421	537	610	200	35	47	45	17	11	42
2024/2025	1.780	7	39	323	81	59	100	89	74	236	154	153	465
2025/2026	1.915	283	330	399	536	322	45	0	0	0	0	0	0
Totale													7.419